PRLD·74065P101·US·equity·Healthcare - Biotechnology-Activist
PRLD (PRELUDE THERAPEUTICS INC) is held by 39 institutional investors as of Q4 2025. Largest holders: BAKER BROS. ADVISORS LP ($29.4M), VANGUARD GROUP INC ($4.1M), TWO SIGMA INVESTMENTS, LP ($2.3M). Net institutional sentiment: Mixed.
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer